These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 7216442)
1. Nature of the cross-protective antigen in subcellular vaccines of Streptococcus pneumoniae. Au CC; Eisenstein TK Infect Immun; 1981 Jan; 31(1):160-8. PubMed ID: 7216442 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of the role of the pneumococcal Forssman antigen (F-polysaccharide) in the cross-serotype protection induced by pneumococcal subcellular preparations. Au CC; Einsenstein TK Infect Immun; 1981 Jan; 31(1):169-73. PubMed ID: 7216443 [TBL] [Abstract][Full Text] [Related]
4. On the immunogenicity of ribosomes and ribosomal proteins isolated from Klebsiella pneumoniae and Streptococcus pneumoniae. Robert D; Michel S; Ivanoff B; Cozzone AJ; Fontanges R Microbiol Immunol; 1981; 25(2):183-94. PubMed ID: 7015078 [TBL] [Abstract][Full Text] [Related]
6. Intranasal Immunization with the Commensal Shekhar S; Khan R; Schenck K; Petersen FC Appl Environ Microbiol; 2019 Mar; 85(6):. PubMed ID: 30683742 [No Abstract] [Full Text] [Related]
7. Immunity to cross-reactive serotypes induced by pneumococcal conjugate vaccines in infants. Yu X; Gray B; Chang S; Ward JI; Edwards KM; Nahm MH J Infect Dis; 1999 Nov; 180(5):1569-76. PubMed ID: 10515817 [TBL] [Abstract][Full Text] [Related]
8. Antibody-independent, interleukin-17A-mediated, cross-serotype immunity to pneumococci in mice immunized intranasally with the cell wall polysaccharide. Malley R; Srivastava A; Lipsitch M; Thompson CM; Watkins C; Tzianabos A; Anderson PW Infect Immun; 2006 Apr; 74(4):2187-95. PubMed ID: 16552049 [TBL] [Abstract][Full Text] [Related]
9. Enhancement of Streptococcus pneumoniae serotype 6B infection in mice after passive immunization with human serum. Aaberge IS; Hvalbye B; Løvik M Microb Pathog; 1996 Aug; 21(2):125-37. PubMed ID: 8844655 [TBL] [Abstract][Full Text] [Related]
10. Serotype distribution of Streptococcus pneumoniae in north-western Greece and implications for a vaccination programme. Levidiotou S; Vrioni G; Tzanakaki G; Pappa C; Gesouli H; Gartzonika C; Papamichail D; Kremastinou J FEMS Immunol Med Microbiol; 2006 Nov; 48(2):179-82. PubMed ID: 17064274 [TBL] [Abstract][Full Text] [Related]
11. Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette-Guérin vaccines expressing pneumococcal surface protein A. Langermann S; Palaszynski SR; Burlein JE; Koenig S; Hanson MS; Briles DE; Stover CK J Exp Med; 1994 Dec; 180(6):2277-86. PubMed ID: 7964500 [TBL] [Abstract][Full Text] [Related]
12. Conjugation of PspA4Pro with Capsular Streptococcus pneumoniae Polysaccharide Serotype 14 Does Not Reduce the Induction of Cross-Reactive Antibodies. da Silva MA; Converso TR; Gonçalves VM; Leite LCC; Tanizaki MM; Barazzone GC Clin Vaccine Immunol; 2017 Aug; 24(8):. PubMed ID: 28637805 [TBL] [Abstract][Full Text] [Related]
13. Lack of cross-protection against invasive pneumonia caused by heterologous strains following murine Streptococcus pneumoniae nasopharyngeal colonisation despite whole cell ELISAs showing significant cross-reactive IgG. Cohen JM; Wilson R; Shah P; Baxendale HE; Brown JS Vaccine; 2013 May; 31(19):2328-32. PubMed ID: 23523406 [TBL] [Abstract][Full Text] [Related]
14. Systemic and mucosal protective immunity to pneumococcal surface protein A. Briles DE; Tart RC; Wu HY; Ralph BA; Russell MW; McDaniel LS Ann N Y Acad Sci; 1996 Oct; 797():118-26. PubMed ID: 8993356 [TBL] [Abstract][Full Text] [Related]
15. The antibody response after immunization with pneumococcal polysaccharide vaccine in splenectomized mice: the effect of re-immunization with pneumococcal antigens. Aaberge IS; Løvik M APMIS; 1996 Apr; 104(4):307-17. PubMed ID: 8645471 [TBL] [Abstract][Full Text] [Related]
16. Nasal vaccination with pneumococcal surface protein A in combination with cationic liposomes consisting of DOTAP and DC-chol confers antigen-mediated protective immunity against Streptococcus pneumoniae infections in mice. Tada R; Suzuki H; Takahashi S; Negishi Y; Kiyono H; Kunisawa J; Aramaki Y Int Immunopharmacol; 2018 Aug; 61():385-393. PubMed ID: 29945026 [TBL] [Abstract][Full Text] [Related]
17. Enhanced protective responses to a serotype-independent pneumococcal vaccine when combined with an inactivated influenza vaccine. Babb R; Chen A; Ogunniyi AD; Hirst TR; Kara EE; McColl SR; Alsharifi M; Paton JC Clin Sci (Lond); 2017 Jan; 131(2):169-180. PubMed ID: 27885052 [TBL] [Abstract][Full Text] [Related]
18. Relationship between surface accessibility for PpmA, PsaA, and PspA and antibody-mediated immunity to systemic infection by Streptococcus pneumoniae. Gor DO; Ding X; Briles DE; Jacobs MR; Greenspan NS Infect Immun; 2005 Mar; 73(3):1304-12. PubMed ID: 15731027 [TBL] [Abstract][Full Text] [Related]